STAAR SURGICAL NAMES NEW EXECUTIVE TO TOP POST
STAAR SURGICAL NAMES NEW EXECUTIVE TO TOP POST MONROVIA, Calif., Nov. 4 /PRNewswire/ STAAR Surgical
(NASDAQ: STAA) announced today the appointment of Vladimir Feingold to the position of vice president of research and development. Feingold will manage ongoing research and development projects as well as bring to fruition the newly announced STAAR Surgical Toric Intraocular (T-IOL)TM lens and the long-awaited STAAR Refractive (Implantable contact) lenses. This post has been vacant since November of 1990 due to the untimely death of Michael Scott, STAAR's former vice president of research and development.
Feingold, who has been a consultant to STAAR Surgical for more than two years, has more than 15 years of research and development experience. Prior to working with STAAR Surgical, Feingold was managing director and executive head of research and development for Bionica Pty Ltd., Australia, where he was involved with: design and development of the ambulatory Medication Delivery System - MDS 110; strategic planning; raising initial Equity Capital; and initial sales and marketing of Bionica's newly United States Food and Drug Administration (FDA) approved products. From 1975 until 1983 Feingold was employed at Telectronics Pty. Ltd., Australia, where in his various positions he was involved in product design and development, product research, and regulatory affairs, including working with the FDA on product submissions and adherence to Good Manufacturing Practices. Feingold left Telectronics to pursue post-graduate study towards his Ph.D. degree. Feingold received a degree in mechanical engineering from the Givatayim School of Engineering in Israel in 1969 and attended the University of Sydney in Australia. In 1973 he received his bachelor of science degree in mathematics and computer sciences. Further study led Feingold to receive a bachelor's of engineering (mechanica) first class honors degree in 1975. Additional study in the areas of medical terminology, management, finance, microprocessors and data acquisition led to Feingold receiving certificates from the Australian Institute of Management between 1977 and 1982. Feingold has published several professional papers on insulin infusion systems and currently holds patents on several devices: 1) Subcutaneous Delivery Device; 2) Implantable Medication Infusion System; and 3) Infusion Pump. STAAR Surgical, a publicly traded company founded in 1982, develops, manufactures and markets products for small-incision surgery, primarily for use in cataract procedures. -0- 11/4/91 /CONTACT: Deborah Kazenelson of Hill and Knowlton, Inc., 213-937-7460, for STAAR Surgical Inc.; or LaMar F. Laster, chairman of STAAR Surgical Inc., 818-303-7902/ (STAA) CO: STAAR Surgical Inc. ST: California IN: HEA SU: PER JL -- LA005 -- 0557 11/04/91 08:05 EST
|Printer friendly Cite/link Email Feedback|
|Date:||Nov 4, 1991|
|Previous Article:||NERCO REPORTS THIRD-QUARTER RESULTS|
|Next Article:||SCIENTIFIC-ATLANTA REPORTS FIRST QUARTER RESULTS|